Tag: Biotechnology Research

AZENTA
United States

AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO

Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass., Sept. 4, 2024 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or “the Company”), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth and successful transition.  Mr. Marotta has two decades … Continue reading AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO

Impact Newswire
Evofem Biosciences
United States

Evofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution

SAN DIEGO, Aug. 20, 2024 / PRNewswire – As the popularity of GLP-1 receptor agonists continues to surge in the treatment of obesity and type 2 diabetes, Evofem Biosciences, Inc. (OTCQB: EVFM) is raising awareness of the potential impact these medications may have on the effectiveness of oral contraceptives. With an increasing number of women turning to GLP-1 medications for weight management and glycemic control, the need … Continue reading Evofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution

Impact Newswire
ICON
Europe

ICON Announces Appointment of New Chief Financial Officer

DUBLIN – ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Nigel Clerkin as its new Chief Financial Officer (CFO). Nigel brings extensive experience and capability to the role of CFO. He commenced his career with KPMG, before joining Elan Corporation where he held a number of roles of increasing responsibility over a fifteen-year career, culminating in the … Continue reading ICON Announces Appointment of New Chief Financial Officer

Impact Newswire
Bio X Cell
Middle East

Bio X Cell Announces CEO Appointment

News provided by Bio X Cell 12 Aug, 2024, 06:00 GMT A Leading Producer of Monoclonal Antibodies LEBANON, N.H., Aug. 12, 2024 /PRNewswire/ — Bio X Cell, LLC (“BXC” or the “Company”), a leading producer of monoclonal antibodies for pre-clinical in vivo research applications, is pleased to announce the appointment of Christopher Conway as Chief Executive Officer. Mr. Conway has extensive experience in both small molecule and Biologics drug discovery, most … Continue reading Bio X Cell Announces CEO Appointment

Impact Newswire